Galician Experiences in Health Innovation Javier Quiles del Río, Galician Health Service - SERGAS. Santiago de Compostela, Spain 1
Why innovation? Challenges: + Ageing + Chronical patients + Limits for Resources = Need for transformation 2
First Question: Why innovation? Let s make an opportunity from a challenge 3
First Question: Why innovation? Innovation is a driver for change 4
What is Innovation? Different meanings depending on who you are The innovative organization is one that seeks Industry (SME/Big Enterprise) to systematically and deliberately doing new things or R&D doing organization the same things in new ways, posing significant Health care Challenges provider and Solutions that provide Health value care to citizens payerand society as a whole Innovation funder or investor 5
Galician Health Service: SERGAS www.sergas.es 5 7 1 Public Healthcare Provider. 95% of a population of 2,7M 2 3 6 GALICIAN HEALTHCARE SERVICE - SERGAS Public Health Authority: CONSELLERIA DE SANIDADE 4 14 12 13 9 8 11 10 Global Resources: 3600 M /Year: 40% Total Galician Budget 14 Secondary Care Trusts and Hospitals 493 Primary Care Centres 90 Emergency Centres + 165 Elderly Homes 7 INTEGRATED HEALTH AREAS
What is innovation? Look for Strategic goals Identify solutions and opportunities (Inside and Outside) For a Healthcare organization Scale up, Deploy and Evaluate Foster building process of solutions 7
How can we make innovation happen? Galicia Health Innovation Platform Multidisciplinary Team 1) Identify strategic goals 2) Search for new ideas and solutions Inside and outside of organization 3) Foster building process of new solutions ->aligned with strategic goals ->keep cost benefit balance 4) Deploying -> support and align projects with operational units - > monitor evaluation and assesment
REPORT REPORT How can we make innovation happen? HEALTH AUTHORITY HEALTH SERVICE BOARD ROLE: TOP-DOWN DRIVEN CHANGES AND SCALE UP HEALTH INNOVATION PLATFORM R&D CENTERS TECHNOLOGY CENTERS PUBLIC ENTITIES INDUSTRY CLUSTERS EU INITIATIVES INNOVATION BOARD HUMAN RESOURCES FINANCIAL RESEARCH ROLE: DEFINE STRATEGICAL CHALLENGES VALIDATE AND PRIORITIZE PROPOSALS HEALTHCARE HEAD MANAGER IT HEAD MANAGER INNOVATIO N HEAD MANAGER RRHH AND KNOWLEDGE AREAS INTERNAL UNITS INFRASTRUCTURES ALL PROFESSIONALS IN GALICIAN HEALTH SERVICE INNOVATION UNIT ROLE: CONTROL INNOVATION PROCESS INNOVATION SPECIALISTS PROJECT MANAGERS SUPORT AND FOSTER INNOVATION ACTIVITIES INNOVATION PROJECTS PARTICIPATE HEALTH CARE CENTERS HEALTH TECHNOLOGY ASSESMENT UNIT PUBLIC HEALTH USER RELATIONSHIP UNIT
1. Identify strategic goals Detecting needs, challenges and priorities in the organization Put the objectives first, and the projects second. - Avoid risk of converting projects in objectives. - Clear reference of the needs of the organization.
2. Foster generation of new ideas and solutions Open channel: listen to innovative and strategic ideas from Inside and Outside: more than 110 ideas from professionals in one year! Open Technical Dialog with companies: 305 proposals of innovative solutions in three years 11
3. Build solutions: from ideas to projects STAGE-GATE MODEL: INCREMENTAL - CHECK FOR VALUE
3.Build solutions: Develop and test Structural funds for large scale deployment of Active and Healthy Ageing developed solutions 1 5 7 2 3 6 4 14 12 13 9 8 11 10
3.Build solutions: Identify funding RDTi Technology ERDF FUNDS 2007-2014 PPI - Public procurement of Innovation PCP Precommercial procurement INNOVA-SAÚDE: 45 M. 14 innovative projects exploring new solutions to provide better healthcare. -> To date: 17 M in PPI H2050: 45 M. 9 innovative projects articulated around the hospital of the future. ->To date: 12 M in PPI http://www.sergas.es/h2050-innovasaude
Development with companies through PPI and PCP: RESULTS Improve public services through innovative solutions (goods or services) Galician Health Service will obtain license free solutions and a value of return Companies will maintain the solutions an average of 4 years. Price decrease has reached 5% average. Foster innovation in companies, especially in SMEs In 80 % of awarded contracts, an SME is engaged. Users Groups are created to define solution in co-creation with each Company with a more than 200 professionals. Promote internationalization and commercialization of innovation internacionalización leveraged by local market for launch 25% of contracts have been awarded to a joint proposal In 73 % of awarded contracts have one or more multinational Company engaged All proposals awarded contain a demonstration phase to evaluate and show final results
4. Scale up, Deploy and Evaluate nnovation should be OPEN educes resistance to change make systemic changes Will always Focus on the User But, in order to Scale Up, Deploy and perform Change management Innovation must top-down driven: be aligned and introduce projects through the operational and Change management units SAMPLES: Galician electronic health record, United4Health, eprescription, ereferrals project
4. Scale up, Deploy and Evaluate And of course EVALUATE RESULTS Work in progress: Common Methodology Include health, service and cost axis Focus on impact: value for health organization, value for companies, value for users Alignment with Stages of innovation DERMATOLOXIA OFTALMOLOXIA CARDIOLOXIA RADIODIAGNOSTICO MEDICINA INTERNA ENDOCRINOLOXIA ANXIOLOXIA E CIRURXIA VASCULAR NEFROLOXIA REUMATOLOXÍA DIXESTIVO PSIQUIATRIA NEUMOLOXIA NEUROLOXIA REHABILITACION Área sanitaria GNA Teleconsulta s con Respuesta 2012 Teleconsulta s con Respuesta 2013 Evolución ANXIOLOXIA E CIRURXIA VASCULAR 0 166 - AREA A CORUÑA DERMATOLOXIA 3.246 3.145 97% ENDOCRINOLOXIA 0 223 - OFTALMOLOXIA 867 1036 119% PSIQUIATRIA 0 27 - AREA FERROL DERMATOLOXIA 33 101 306% OFTALMOLOXIA 1.782 2.002 112% AREA LUGO DERMATOLOXIA 78 183 235% OFTALMOLOXIA 95 88 93% CARDIOLOXIA 11 466 4236% DERMATOLOXIA 713 857 120% DIXESTIVO 42 ENDOCRINOLOXIA 18 AREA OURENSE MEDICINA INTERNA 152 498 328% NEFROLOXIA 0 120 - NEUMOLOXIA 0 23 - OFTALMOLOXIA 884 802 91% RADIODIAGNOSTICO 2.843 3.836 135% AREA PONTEVEDRA DERMATOLOXIA 529 988 187% OFTALMOLOXIA 385 220 57% DERMATOLOXIA 851 890 105% AREA SANTIAGO ENDOCRINOLOXIA 149 29 19% NEUROLOXIA 10 15 150% OFTALMOLOXIA 926 796 86% CARDIOLOXIA 663 4.388 662% DERMATOLOXIA 3.946 5.698 144% AREA VIGO OFTALMOLOXIA 121 302 250% REHABILITACION 5 13 260% REUMATOLOXÍA 0 116-18289 27088 148% 0 4000 8000 12000
Innovation will come if we make it work altogether Look for Strategic goals Identify solutions Inside and outside For a Healthcare organization Scale up, Deploy and Evaluate Foster building process of solutions Thank you 18